(via TheNewswire)
Cytophage developed OvaPhage based on its proprietary bacteriophage technology, and has tested it in its laboratories over the past 9 months. Cytophage is now preparing for field trials which will involve testing the product in poultry barns. OvaPhage will be sprayed on the eggs using the existing closed spray systems available in poultry barns. The Company’snational poultry advisor has indicated that Canadian egg producers would welcome new products that will decrease spoilage and increase revenues while not requiring new application processes.
To facilitate this step, an Experimental Studies Certificate application is being prepared for submission to the
“OvaPhage is one of several product developments that Cytophage aims to commercialize in 2024 with our proprietary bacteriophage technology,” said Dr Steven Theriault, CEO of Cytophage. “
For media inquiries:
President
heather@cytophage.com
431 388 8873
About Cytophage:
Cytophage is a pioneering biotechnology company dedicated to bacteriophage research, product development and commercialization. Committed to addressing the global challenge of antibiotic resistance, Cytophage advances innovative products that harness the power of bacteriophages to combat bacterial infections affecting human health, animal health, and food security.
Cautionary Statement on Forward-Looking Information
This news release contains “forward-looking information” and “forward-looking statements” (collectively, “forward-looking statements”) within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Cytophage to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Factors that could cause actual results to differ materially from those anticipated in these forward-looking statements are described under the caption “Risk Factors” in Cytophage’s Filing Statement dated
Copyright (c) 2024 TheNewswire - All rights reserved.
Copyright (c) 2024 TheNewswire - All rights reserved., source